PTPN12 decreases neurite-like outgrowth in TrkB-SH-SY5Y cells. by Malene Ambjørn (421718)

Decreased cell viability and ROS production induced by oxidative treatment. by Sandra M. Martín-Guerrero (780940)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)

Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

“…Error bars represent standard error of mean. C) TF expression level linearly correlates with decreased frequency of CD45+ cells. …”

<i>B. bassiana</i> decreased longevity and impaired climbing. by Deepanshu N. D. Singh (20721878)

UVB irradiation decreased TM expression in HaCaT cells. by Huey-Chun Huang (429098)

“…<p>(A) HaCaT Cells were exposed to UVB irradiation in a dose-response (0, 1.5, 3, 4.5, 6 mJ/cm²) Cell viability was examined by trypan blue exclusion. …”

Nicotine decreased Wnt5a expressions in SK-BR-3 cells. by Masanori A. Murayama (5774585)

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

Lethal toxin decreases IL-22 production in human ILCs. by Sudarshan Seshadri (370894)

Grb2 silencing decreases phagocytic uptake in RPE cells. by Shameka J. Shelby (279119)

L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency. by Rodrigo Velázquez-Moctezuma (3776023)

Afatinib decreases MAPK and AKT activation after MET knockdown. by Karolin Ebert (7434713)

Decreased HbNO production in HbE/ß-thal subjects. by Attaphon Chamchoi (5774669)

ML246 and voluntary exercise decrease cerebral amyloid plaques and ameliorate memory deficits in 5XFAD AD mice. by Altea Rocchi (3278457)

Reverse activation tendency decreases for spikes occurring later in SWRs by Jozsef Csicsvari (82625)

Decreased cytokine production by moDCs upon TLR stimulation when preincubated with NSAIDs. by Tonke K. Raaijmakers (13955749)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

R848 mediated RANTES, but not TNF-α production, is significantly decreased in TRAM^−/− iBMDMs. by Enda Shevlin (628477)

Inhibition of IL-17A at tumor sites decreases the intratumoral microvessel density. by Keiji Hayata (277090)

“…<p>(A) The endothelial maker CD31-stained sections of tumor tissue are shown in Ad-SNC and Ad-si-IL-17 treatment models, Ad-si-IL-17 treatment decreased the intratumoral microvessel density compared with Ad-SNC. …”